World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: IRCT
Last refreshed on: 11 September 2018
Main ID:  IRCT2017022022965N6
Date of registration: 2017-09-03
Prospective Registration: No
Primary sponsor: Hamedan University of Medical Sciences
Public title: Comparing the effect of vitamin D weekly with daily in treatment of patients with vitamin D deficiency
Scientific title: Comparing the effect of 50000 units vitamin D weekly with 7000 units daily in treatment of patients with vitamin D deficiency
Date of first enrolment: 2017-08-23
Target sample size: 130
Recruitment status: Complete
URL:  http://en.irct.ir/trial/19700
Study type:  interventional
Study design:  Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Patients assign into weekly treatment group or daily treatment group with simple randomization method, Randomization description: Simple randomization by sealed envelopes, Blinding description: This study was performed as a double-blind randomized clinical trial. Patients and researcher were blinded.  
Phase:  4
Countries of recruitment
Iran (Islamic Republic of)
Contacts
Name: Maryam Mehrpooya   
Address:  Hamedan University of Medical Sciences, Shahid Fahmide avenue, Hamedan 65178 Hamedan Iran (Islamic Republic of)
Telephone: +98 81 3838 1675
Email: m_mehrpooya2003@yahoo.com
Affiliation:  Hamedan University of Medical Sciences
Name: Maryam Mehrpooya   
Address:  Hamedan University of Medical Sciences, Shahid Fahmide avenue, Hamedan 65178 Hamedan Iran (Islamic Republic of)
Telephone: +98 81 3838 1675
Email: m_mehrpooya2003@yahoo.com
Affiliation:  Hamedan University of Medical Sciences
Key inclusion & exclusion criteria
Inclusion criteria: patients aged 18 years old and more
levels of 25 hydroxy vitamin D below 30 nmol per liter

Exclusion criteria: Patient treated with vitamin D supplements during the past 3 months
pregnant women
lactating women
patients with cognitive and psychiatric disorders that are not able to attend and complete the study
patients who cannot receive oral medication
patients with hyper-calcaemia, hypo-calcaemia
patients with hyper-phosphatemia And Hypo-Phosphatemia
Patients with Advanced Liver Diseases
Patients with Renal Disease
Patients receiving drugs that affect serum levels of vitamin D (phenytoin, phenobarbital, carbamazepine, valproate, etc.)


Age minimum: no limit
Age maximum: no limit
Gender: Both
Health Condition(s) or Problem(s) studied
Vitamin D deficiency.
Avitaminosis D
Intervention(s)
Intervention 1: intervention group: 7000 units of vitamin D once a day for 8 weeks. Intervention 2: intervention group: 50000 units of vitamin D once weekly for 8 weeks.
Primary Outcome(s)
Vitamin D deficiency. Timepoint: at baseline, at the end of study. Method of measurement: Blood sample.
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Hamedan University of Medical Sciences
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Ethics Committee of the Hamedan University of Medical Sciences
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history